Journal of the American Society of Hypertension
Volume 2, Issue 4, Supplement , Pages S3-S9 , July 2008

The broadening landscape for hypertension management

Based on material presented at a Boehringer Ingelheim-Sponsored Meeting held in Madrid, Spain, May 4–5, 2007.

  • Giuseppe Mancia, MD

      Affiliations

    • Corresponding Author InformationCorresponding author: Giuseppe Mancia, MD, Clinica Medica, Dipartmento di Medicina Clinica e Prevenzione, Università Milano-Bicocca, Ospedale San Gerardo, Monza, Milan, Italy. Tel: +39 039 233 3357; fax: +39 039 322274.

References 

  1. Zanchetti A. Evidence-based medicine in hypertension: what type of evidence?. J Hypertens. 2005;23:1113–1120
  2. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet. 2000;356:1955–1964
  3. Blood Pressure Lowering Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003;362:1527–1535
  4. Weber MA, Julius S, Kjeldsen SE, Brunner HR, Ekman S, Hansson L, et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALE trial. Lancet. 2004;363:2047–2049
  5. Pepine CJ, Kowey PR, Kupfer S, Kolloch RE, Benetos A, Mancia G, et al. Predictors of adverse outcome among patients with hypertension and coronary artery disease. J Am Coll Cardiol. 2006;47:547–551
  6. Arima H, Chalmers J, Woodward M, Anderson C, Rodgers A, Davis S, et al. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens. 2006;24:1201–1208
  7. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033–1041
  8. Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, et al. ADVANCE Collaborative Group Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomized controlled trial. Lancet. 2007;370:829–840
  9. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population (Follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study). Circulation. 2005;111:1777–1783
  10. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47:846–853
  11. Mancia G. Effective ambulatory blood pressure control in medical practice (Good news to be taken with caution). Hypertension. 2007;49:17–18
  12. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Quarti Trevano F, et al. Long-term prognostic value of blood pressure variability in the general population. Hypertension. 2007;49:1265–1270
  13. Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens. 2002;20:1461–1464
  14. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens. 2004;22:435–445
  15. Mancia G, Ambrosioni E, Rosei EA, Leonetti G, Trimarco B, Volpe M. Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the FORLIFE study. J Hypertens. 2005;23:1575–1581
  16. Andersson OK, Almgren T, Persson B, Samuelsson O, Hedner T, Wilhelmsen L. Survival in treated hypertension: follow-up study after two decades. BMJ. 1998;317:167–171
  17. Mancia G, Volpe R, Boros S, Ilardi M, Giannattasio C. Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care. J Hypertens. 2004;22:51–57
  18. Mancia G, Facchetti R, Bombelli M, Friz HP, Grassi G, Giannattasio C, et al. Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension. 2005;45:1072–1077
  19. Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial — Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003;361:1149–1158
  20. Mancia G. Role of outcome trials in providing information on antihypertensive treatment: importance and limitations. Am J Hypertens. 2006;19:1–7
  21. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus. Arch Intern Med. 2005;165:1410–1419
  22. Mancia G. Total cardiovascular risk: a new treatment concept. J Hypertens. 2006;24:S17–S24
  23. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (A meta-analysis). J Am Coll Cardiol. 2005;45:1832–1839
  24. Mancia G, Grassi G, Zanchetti A. New-onset diabetes and antihypertensive drugs. J Hypertens. 2006;24:3–10
  25. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press. 2007;16:135–232
  26. Hypertension Detection and Follow-Up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-Up Program (I. Reduction in mortality of persons with high blood pressure, including mild hypertension). JAMA. 1979;242:2562–2572

 Conflict of interest: none.

PII: S1933-1711(08)00039-9

doi: 10.1016/j.jash.2008.03.003

Journal of the American Society of Hypertension
Volume 2, Issue 4, Supplement , Pages S3-S9 , July 2008

Article Tools

* Image Usage & Resolution